Title of article
Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial
Author/Authors
Simon J Meggitt، نويسنده , , Janine C Grayand، نويسنده , , Nick J Reynolds، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2006
Pages
8
From page
839
To page
846
Abstract
Background
Atopic eczema affects 1–2% of adults, and can cause considerable morbidity. We aimed to assess the safety and efficacy of azathioprine as systemic monotherapy for moderate-to-severe atopic eczema, and the therapeutic importance of the thiopurin
Journal title
The Lancet
Serial Year
2006
Journal title
The Lancet
Record number
589359
Link To Document